A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS-CoV-2.

Malik, Prerna; Jain, Sonika; Jain, Pankaj; Kumawat, Jyoti; Dwivedi, Jaya; Kishore, Dharma

Malik, Prerna; Jain, Sonika; Jain, Pankaj; Kumawat, Jyoti; Dwivedi, Jaya; Kishore, Dharma.

Afiliação

Malik P; Department of Chemistry, Banasthali Vidyapith, Jaipur, India.
Jain S; Department of Chemistry, Banasthali Vidyapith, Jaipur, India.
Jain P; Department of Pharmacy, Banasthali Vidyapith, Jaipur, India.
Kumawat J; Department of Chemistry, Banasthali Vidyapith, Jaipur, India.
Dwivedi J; Department of Chemistry, Banasthali Vidyapith, Jaipur, India.
Kishore D; Department of Chemistry, Banasthali Vidyapith, Jaipur, India.

Arch Pharm (Weinheim) ; 355(5): e2100382, 2022 May.

Article em En | MEDLINE | ID: mdl-35040187

Assuntos

Tratamento Farmacológico da COVID-19; SARS-CoV-2; Antivirais/farmacologia; Antivirais/uso terapêutico; Humanos; Pandemias; Relação Estrutura-Atividade

Palavras-chave

COVID-19 pandemic; Delta+ variant; SARS-CoV-2 variant; lopinavir; remdesivir

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google